SyntheticMR
SyntheticMR: New acting CEO appointed - SEB (SEB Research)
The company has announced that newly appointed CEO Vedran Beglerbegovic has resigned from his position as CEO for medical reasons. Johanna Norén, who has been CFO since 2020, has been appointed acting CEO. The board will begin a recruitment process for a new CEO. We view the timing of the leadership uncertainty as unfortunate, given the recent closure of the Combinostics acquisition.
SEB Research
This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.